Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG)
Completed · Phase 2/Phase 3
Conditions studied: Carcinoma in Situ, Bladder Cancer
In brief
This is a Phase II/Phase III study of intravesical AD 32 (valrubicin) in patients with carcinoma in situ (CIS) who have been previously treated with intravesical Bacillus Calmette-Guerin (BCG) for CIS and in whom recurrence or failure has occurred after multiple courses of intravesical treatment.
Key facts
- Study ID
- NCT01316874
- Run by
- Endo USA Inc., a Keenova Therapeutics Company
- People needed
- 90
- Starts
- 1993-11-01
- Expected to finish
- 1997-04-01
- Last updated by the study team
- 2015-06-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stacy Childs, MD — Alabaster, Alabama, United States
- William Bohnert, MD — Phoenix, Arizona, United States
- Scott Swanson, MD — Scottsdale, Arizona, United States
- Bruce Dalkin, MD — Tucson, Arizona, United States
- Donald Gleason, MD — Tucson, Arizona, United States
- William Friedel, MD — La Mesa, California, United States
- Stephen Auerbach, MD — Newport Beach, California, United States
- William Moseley, MD — San Diego, California, United States
- Standley Brosman, MD — Santa Monica, California, United States
- Eugene Dula, MD — Van Nuys, California, United States
- B. Thomas Brown, MD — Daytona Beach, Florida, United States
- Charles Jackson, MD — Fort Lauderdale, Florida, United States
- Marc Soloway, MD — Miami, Florida, United States
- Charles Brendler, MD — Chicago, Illinois, United States
- Patrick Guinan, MD — Chicago, Illinois, United States
- Jeffrey Ignatoff, MD — Evanston, Illinois, United States
- David Wood, MD — Lexington, Kentucky, United States
- John Tuttle, MD — Lexington, Kentucky, United States
- Dennis Venable, MD — Shreveport, Louisiana, United States
- Harold Frazier, MD — Bethasda, Maryland, United States
- Myron Murdock, MD — Greenbelt, Maryland, United States
- John Libertino — Burlington, Massachusetts, United States
- W. Lamar Weems, MD — Jackson, Mississippi, United States
- Hugh Fisher, MD — Albany, New York, United States
- Michael Blute, MD — Rochester, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.